Steris (NYSE: STE) reported Q3 EPS of $2.14, $0.01 better than the analyst estimate of $2.13. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.33 billion.

Fiscal 2025 Outlook Reiterated
For fiscal 2025, the Company continues to expect as reported revenue to increase 6.5-7.5%. Based on forward rates through March 31, 2025, currency is expected to be slightly favorable to revenue in fiscal 2025. Constant currency organic revenue from continuing operations is anticipated to increase 6-7%. Adjusted earnings per diluted share from continuing operations is anticipated to be in the range of $9.05 to $9.25 compared with $8.20 in adjusted earnings from continuing operations in fiscal 2024. The fiscal 2025 outlook assumes an effective tax rate of approximately 23%. Capital expenditures are anticipated to be approximately $360 million and free cash flow is expected to be approximately $700 million.

For earnings history and earnings-related data on Steris (STE) click here.